TAMBORINO, Carmine
 Distribuzione geografica
Continente #
NA - Nord America 2.176
EU - Europa 1.388
AS - Asia 348
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 5
SA - Sud America 1
Totale 3.924
Nazione #
US - Stati Uniti d'America 2.175
IT - Italia 944
CN - Cina 232
UA - Ucraina 117
TR - Turchia 93
DE - Germania 82
GB - Regno Unito 82
SE - Svezia 38
FI - Finlandia 34
FR - Francia 28
AT - Austria 24
PL - Polonia 16
BE - Belgio 10
HK - Hong Kong 10
AU - Australia 5
A2 - ???statistics.table.value.countryCode.A2??? 3
AL - Albania 3
EU - Europa 3
IN - India 3
IR - Iran 3
NL - Olanda 3
VN - Vietnam 3
HU - Ungheria 2
JP - Giappone 2
RO - Romania 2
CO - Colombia 1
ES - Italia 1
GE - Georgia 1
GR - Grecia 1
HN - Honduras 1
KR - Corea 1
PT - Portogallo 1
Totale 3.924
Città #
Woodbridge 318
Fairfield 252
Houston 198
Chandler 189
Ashburn 168
Rome 153
Ann Arbor 136
Jacksonville 134
Wilmington 88
Seattle 82
Cambridge 79
Ferrara 64
Milan 61
Florence 50
Nanjing 47
Beijing 45
New York 44
Izmir 42
Princeton 39
Boardman 36
Shanghai 28
Dearborn 26
Vienna 24
Bremen 22
Addison 19
San Diego 19
Nanchang 17
Warsaw 16
Los Angeles 15
Jiaxing 13
Bologna 12
Padova 11
Shenyang 11
Brussels 10
Cagliari 10
Hebei 10
Hong Kong 10
Norwalk 10
Tianjin 10
Naples 9
Verona 9
Terni 8
Changsha 7
Jinan 7
Prato 7
Redwood City 7
Venice 7
Bari 6
London 6
Mountain View 6
San Mateo 6
Turin 6
Auburn Hills 5
Hefei 5
Marino 5
San Giovanni la Punta 5
Taranto 5
Washington 5
Zhengzhou 5
Casale Marittimo 4
Gioia Tauro 4
Guangzhou 4
La Spezia 4
Paris 4
Reggio Emilia 4
Rieti 4
Rimini 4
San Benedetto del Tronto 4
Tappahannock 4
Bergamo 3
Brescia 3
Campi Bisenzio 3
Casarsa della Delizia 3
Chieti 3
Cittanova 3
Cornedo Vicentino 3
Des Moines 3
Dong Ket 3
Falls Church 3
Fano 3
Formia 3
Fucecchio 3
Indiana 3
Latina 3
Macerata 3
Orange 3
Osio Sotto 3
Palermo 3
Piacenza 3
Pistoia 3
San Francisco 3
Sant'elena 3
Shaoxing 3
Telve 3
Teramo 3
Tuscania 3
Aprilia 2
Bassano del Grappa 2
Canepina 2
Carinaro 2
Totale 2.773
Nome #
Affidabilità delle mappe TC perfusionali nel definire il core infartuale e la penombra ischemica in pazienti con ictus ischemico acuto 904
Timing of serum active MMP-9 and MMP-2 levels in acute and subacute phases after spontaneous intracerebral hemorrhage 130
Epstein-Barr virus-specific antibody response in cerebrospinal fluid and serum of patients with multiple sclerosis 129
Interplay between Matrix Metalloproteinase-9, Matrix Metalloproteinase-2, and Interleukins in Multiple Sclerosis Patients 120
Biological markers in cerebrospinal fluid for axonal impairment in multiple sclerosis: acetylcholinesterase activity cannot be considered a useful biomarker 119
Epstein-Barr virus-specific intrathecal oligoclonal IgG production in relapsing-remitting multiple sclerosis is limited to a subset of patients and is composed of low-affinity antibodies 119
Serum osteopontin levels are upregulated and predict disability after an ischaemic stroke 116
Cerebrospinal fluid amounts of HLA-G in dimeric form are strongly associated to patients with MRI inactive multiple sclerosis 116
Adding blood to agitated saline significantly improves detection of right-to-left shunt by contrast-transcranial color-coded duplex sonography 113
Chlamydia pneumoniaespecific intrathecal oligoclonal antibody response is predominantly detected in a subset of multiple sclerosis patients with progressive forms 111
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 110
Leptin/adiponectin ratio predicts post-stroke neurological outcome 109
Matrix metalloproteinase-9 activity detected in body fluids is the result of two different enzyme forms 105
Potential relevance of cerebrospinal fluid and serum levels and intrathecal synthesis of active matrix metalloproteinase-2 (MMP-2) as markers of disease remission in patients with multiple sclerosis 105
null 97
Timing of serum soluble HLA-G levels in acute and subacute phases after spontaneous intracerebral hemorrhage. 90
null 90
null 88
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES Identification of a TIMP-1-resistant active MMP-9 in serum of Multiple Sclerosis patients 87
Affinity distribution of anti-EBV IgG in the cerebrospinal fluid of patients with multiple sclerosis and in controls 84
DNA Sequences of Parachlamydia-like organisms in CSF of Patients with Neurological Disorders 79
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS 77
Relapsing-remitting neurological bladder as onset of immune-mediated vasculitis of spinal cord (MPO-ANCA) 76
Quantification of CSF and serum levels and intrathecal synthesis of anti-EBV antibodies in patients with multiple sclerosis and with other neurological disorders. 75
ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR THE IMPLEMENTATION A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES IN MS. 72
null 66
Increased age and male sex are independently associated with higher frequency of blood-cerebrospinal fluid barrier dysfunction using the albumin quotient 66
null 66
Elevated CSF and serum levels and intrathecal synthesis of active MMP-2 in MS patients with no evidence of MRI disease activity 62
Possibile association between cerebrospinal fluid and serum levels of active matrix metalloproteinase-2 and MRI inactivity in multiple sclerosis patients 59
Detection of Chlamydia pneumoniae-specific intrathecal oligoclonal antibody response in a subset of patients with progressive forms of multiple sclerosis 54
null 45
MMP-9 isoforms in serum of Multiple Sclerosis patients 41
null 40
CSF levels and soluble HLA-G and Fas molecules are inversely associated to MRI evidence of disease activity in patients with relapsing-remitting multiple sclerosis 40
Effect of HLA-G gene polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 31
CEREBROSPINAL FLUID AND SERUM LEVELS OF ANTI-CHLAMYDIA PNEUMONIAE IGA IN PATIENTS WITH MULTIPLE SCLEROSIS - ERMES: EMILIA ROMAGNA MULTIPLE SCLEROSIS. REGIONAL NETWORK FOR IMPLEMENTING A BIOLOGICAL BANK TO IDENTIFY MARKERS OF DISEASE ACTIVITY RELATED TO CLINICAL VARIABLES. 31
EBV-specific intrathecal oligoclonal antibody response in multiple sclerosis patients 26
Effects of anticoagulants on the activity of gelatinases 19
Effects of anticoagulants on the activity of gelatinases 16
Role of HLA-G 14bp deletion/insertion and +3142C>G polymorphisms in the production of sHLA-G molecules in relapsing-remitting multiple sclerosis. 10
Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-dimer molecules in cerebrospinal fluids from MS stable patients. 6
Totale 3.999
Categoria #
all - tutte 13.257
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 13.257


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019140 0 0 0 0 0 0 0 0 0 0 0 140
2019/2020702 116 31 26 87 44 80 76 69 59 75 27 12
2020/2021431 39 31 15 47 17 33 20 49 22 65 61 32
2021/2022420 15 50 28 30 7 20 13 26 13 34 34 150
2022/2023790 42 65 26 83 112 76 61 65 103 29 60 68
2023/2024674 35 33 35 38 101 202 28 68 33 34 53 14
Totale 3.999